JYSB2000486 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-30 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Filed | 2020-10-19 | view |
JYSB2000487 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-30 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Filed | 2020-10-19 | view |
JYSB2000349 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-07-04 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-09-17 | view |
JYSB2000347 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-07-04 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-09-17 | view |
JYSB2000237 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-08-20 | view |
JYSB2000236 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-08-20 | view |
JYSB2000235 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-08-20 | view |
JYSB2000233 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-08-11 | view |
JYSB2000234 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-08-20 | view |
JYSB2000232 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-07-23 | view |
JYSB2000247 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-06-12 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Filed | 2020-06-19 | view |
JYSB1900290 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2019-10-23 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | In Review | 2021-03-19 | view |
JXSS1900053 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2019-08-17 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-03-30 | view |
JXSS1900055 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2019-08-17 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-03-30 | view |
JXSS1900054 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2019-08-17 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2020-03-30 | view |
JYSB1900144 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2019-07-08 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2019-09-16 | view |
JYSZ1900039 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2019-07-08 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2019-11-27 | view |
JYSB1900145 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2019-07-08 | AbbVie Ltd | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | Certificate Issued | 2019-09-16 | view |
JYHB1900318 | 奥比帕利片 | | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2019-03-18 | AbbVie Ltd | Abbvie Ltd;Fournier Laboratories Ireland Ltd | Certificate Issued | 2019-05-28 | view |
JYHB1900319 | 达塞布韦钠片 | Dasabuvir Sodium | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2019-03-18 | AbbVie Ltd | Abbvie Ltd;Abbvie Ireland Nl BV | Certificate Issued | 2019-05-28 | view |